Publications of Susanne Lucae
All genres
Journal Article (198)
61.
Journal Article
69, pp. 161 - 171 (2016)
Time-dependent effects of dexamethasone plasma concentrations on glucocorticoid receptor challenge tests. PSYCHONEUROENDOCRINOLOGY 62.
Journal Article
2 (6), e1501678 (2016)
Novel multiple sclerosis susceptibility loci implicated in epigenetic regulation. SCIENCE ADVANCES 63.
Journal Article
21 (2), pp. 277 - 289 (2016)
FKBP51 inhibits GSK3 beta and augments the effects of distinct psychotropic medications. MOLECULAR PSYCHIATRY 64.
Journal Article
6, e950 (2016)
Proliferation rates and gene expression profiles in human lymphoblastoid cell lines from patients with depression characterized in response to antidepressant drug therapy. TRANSLATIONAL PSYCHIATRY 65.
Journal Article
71 (1), pp. 115 - 118 (2016)
IgE responses to exogenous and endogenous allergens in atopic dermatitis patients under long-term systemic cyclosporine A treatment. ALLERGY 66.
Journal Article
5, e678 (2015)
Genome-wide analysis implicates microRNAs and their target genes in the development of bipolar disorder. TRANSLATIONAL PSYCHIATRY 67.
Journal Article
25 (6), pp. 864 - 872 (2015)
IGF-I in major depression and antidepressant treatment response. EUROPEAN NEUROPSYCHOPHARMACOLOGY 68.
Journal Article
20 (6), pp. 735 - 743 (2015)
The association between lower educational attainment and depression owing to shared genetic effects? Results in similar to 25 000 subjects. MOLECULAR PSYCHIATRY 69.
Journal Article
13, 86 (2015)
A genetic risk score combining 32 SNPs is associated with body mass index and improves obesity prediction in people with major depressive disorder. BMC MEDICINE 70.
Journal Article
5, e538 (2015)
RNA expression profiling in depressed patients suggests retinoid-related orphan receptor alpha as a biomarker for antidepressant response. Translational psychiatry 71.
Journal Article
18 (2), pp. 199 - 209 (2015)
Psychiatric genome-wide association study analyses implicate neuronal, immune and histone pathways. NATURE NEUROSCIENCE 72.
Journal Article
8 (404), p. ra119 - ra119 (2015)
Chaperoning epigenetics: FKBP51 decreases the activity of DNMT1 and mediates epigenetic effects of the antidepressant paroxetine. Science signaling 73.
Journal Article
40 (2), pp. 361 - 371 (2015)
XRCC5 as a Risk Gene for Alcohol Dependence: Evidence from a Genome-Wide Gene-Set-Based Analysis and Follow-up Studies in Drosophila and Humans. NEUROPSYCHOPHARMACOLOGY 74.
Journal Article
76 (6), pp. e802 - e808 (2015)
Clinical risk factors for weight gain during psychopharmacologic treatment of depression: results from 2 large German observational studies. The Journal of clinical psychiatry 75.
Journal Article
16 (7), pp. 689 - 701 (2015)
CHL1, ITGB3 and SLC6A4 gene expression and antidepressant drug response: results from the Munich Antidepressant Response Signature (MARS) study. PHARMACOGENOMICS 76.
Journal Article
11 (11), e1001755 (2014)
Association of FKBP51 with Priming of Autophagy Pathways and Mediation of Antidepressant Treatment Response: Evidence in Cells, Mice, and Humans. PLOS MEDICINE 77.
Journal Article
76 (7), pp. E15 - E17 (2014)
Blood Mononuclear Cell Proteome Suggests Integrin and Ras Signaling as Critical Pathways for Antidepressant Treatment Response. BIOLOGICAL PSYCHIATRY 78.
Journal Article
165 (5), pp. 428 - 437 (2014)
Genetic Relationships Between Suicide Attempts, Suicidal Ideation and Major Psychiatric Disorders: A Genome-Wide Association and Polygenic Scoring Study. AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS 79.
Journal Article
19 (2), pp. 165 - 175 (2014)
The clinical application of ABCB1 genotyping in antidepressant treatment: a pilot study. CNS SPECTRUMS 80.
Journal Article
5, 3339 (2014)
Genome-wide association study reveals two new risk loci for bipolar disorder. NATURE COMMUNICATIONS